Conferences - Results from #8660

SUFU 2018: AUA/SUFU SUI Guidelines March 1, 2018

SUFU 2018: Effect of Age on Outcomes Of Transvaginal Native Tissue Repairs for Apical Vaginal Prolapse March 1, 2018

SUFU 2018: Accuracy of Three Non-Invasive Methods for Bladder Void Volume Analysis in Healthy Volunteers March 1, 2018

SUFU 2018: Female Pelvic Floor Mechanics: Analysis of Pressure Data and Imaging March 1, 2018

SUFU 2018: Urinary Levels of Monocyte Chemoattractant Protein-1 Predict the Severity of Symptoms and Response to Treatment In Patients with Overactive Bladder March 1, 2018

SUFU 2018: Understanding the Pathogens Responsible for Recurrent Urinary Tract Infections in Postmenopausal Women March 1, 2018

SUFU 2018: Overexpression of Estrogen Receptor Β in Urothelium Protects Against Uropathogenic E. Coli Urinary Tract Infection March 1, 2018

SUFU 2018: What Can the Core Facilities Offer to the Urology Research Community? NIH-Funded Flagship (O'Brien) Research Centers March 1, 2018

SUFU 2018: Nerve Stimulation Increases Voiding Efficiency in a Novel Model of Detrusor Underactivity February 28, 2018

SUFU 2018: Myogenic Mechanisms of Detrusor Overactivity in Spinal Cord Injury February 28, 2018

SUFU 2018: The Uropathogenic Escherichia Coli Pilus Usher Controls Pilus Assembly Through a 2-Step Verification Process During Activation February 28, 2018

SUFU 2018: Analysis of Versican and Hyaluronan Deposition - Fibrotic and Inflammatory Response to Polypropylene Mesh in Women Undergoing Pelvic Floor Mesh Removal February 28, 2018

SUFU 2018: Neuroanatomical Evaluation of Peri-Vesical Nerve Plexus in Female with 3t-Mr Diffusion Tensor Imaging February 28, 2018

SUFU 2018: Characterization of Bacteria Identified on Explanted Mesh Slings Using Next-Generation Sequencing Techniques February 28, 2018

ASCO GU 2018: Erdafitinib, (FGFR) a Pan-fibroblast Growth Factor Receptor Inhibitor, in Patients with Metastatic or Unresectable Urothelial Carcinoma and FGFR Alterations February 16, 2018

ASCO GU 2018: Phase II Trial of 6 Months ADT/Abiraterone Acetate Plus Prednisone and Definitive Radiotherapy - Intermediate to High Risk Localized Prostate Cancer - AbiRT Trial February 14, 2018

ASCO GU 2018: Expression of Immune Checkpoints on Circulating Tumor Cells in Men with Metastatic Prostate Cancer February 14, 2018

ASCO GU 2018: Clinical Utility of Foundation One Tissue Molecular Profiling in Men with Metastatic Prostate Cancer February 14, 2018

ASCO GU 2018: Patterns of Progression in Bone and Soft Tissue Following Treatment with Ra-223 in Metastatic Castrate Resistant Prostate Cancer February 14, 2018

ASCO GU 2018: The CLEAR study: A Phase 3 Trial to Compare Efficacy and Safety of Lenvatinib in Combination with Everolimus or Pembrolizumab Versus Sunitinib Alone in First-line Treatment of Patients with Metastatic Renal Cell Carcinoma February 14, 2018

Page 434 of 616